¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѽÉÀåÇÐȸ ¿µÈ£³²Áöȸ ¿¬¼ö°­Á : 2023-10-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѽÉÀåÇÐȸ ¿µÈ£³²Áöȸ ¿¬¼ö°­Á : 2023-10-28
±³À°ÀÏÀÚ : 2023-10-28
±³À°Àå¼Ò : ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë(ºÎ»ê¿ª)

±³À°ÁÖÁ¦ : 2023 ´ëÇѽÉÀåÇÐȸ ¿µÈ£³²Áöȸ ¿¬¼ö°­ÁÂ

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ

´ã´çÀÚ : ºÎ¿ï°æ½ÉÀåÇÐȸ
¿¬¶ôó : 051-711-6902

À̸ÞÀÏ : sericonf@gmail.com

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í »çÀüµî·Ï¸µÅ© : https://forms.gle/NM2noNWYdzfU9si98


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 13:00~13:15 Side branch protection strategies in Bifurcation PCI ³²Ã¢¿í(°è¸íÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 13:15~13:30 Antithrombotics 1 year after complex PCI in patetints with AF Á¶À翵(¿ø±¤ÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 13:30~13:45 New drugs for managements of dyslipidemia in very high risk AVSCD patients ¹Ú¿ëȯ(â¿ø»ï¼º)

Åä·Ð 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 13:45~14:00 Discussion ¹Ú°æÀÏ,¼Õâ¹è,ÇãÁ¤È£,À±¿ø½Ä,¹Ú±ÙÈ£,½ÉµÎ¼±,±è¿õ,ÀÌÇö»ó,·ùÀç±Ù(µ¿¾Æ´ëº´¿ø,¿ï»ê´ëº´¿ø,°í½Å´ëº¹À½º´¿ø,ÀüºÏ´ëº´¿ø,Á¶¼±´ëº´¿ø,Àü³²´ëº´¿ø,¿µ³²´ëº´¿ø,±¸¹ÌÂ÷º´¿ø,´ë±¸°¡Å縯´ëº´¿ø)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:00~14:15 New concepts in the diagnosis of hypertrophic cardiomyopathy ÀÌÀÚ¿¬(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:15~14:30 Advances in assessment of secondary tricuspid regurgitation ³²Á¾È£(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:30~14:45 Assessing patients before, during and after treatment in cancer patients ¹ÚÁ¾¿À(ÇØ¿î´ë¹éº´¿ø)

Åä·Ð 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 14:45~15:00 Discussion ¾È¼­Èñ,±è°èȯ,ÃÖÁ¤Çö,Àü¼ºÈñ,±èÇö¿í,±èÈ«³â,ÀÌÈñÁ¤,À±Àç¿ë(¿ï»ê´ëº´¿ø,°æ»ó±¹¸³´ëº´¿ø,ºÎ»ê´ëº´¿ø,¿¹¼öº´¿ø,±¤Áֱ⵶º´¿ø,°æºÏ´ëº´¿ø,°è¸í´ëº´¿ø,±¸¹ÌÂ÷º´¿ø)

ÈÞ½Ä 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:00~15:15 Break ()

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:15~15:30 Novel insights in reflex vasovagal syncope ¾ÈÁøÈñ(ºÎ»ê´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:30~15:45 Leadless Pacemakers in Patients With TAVI ±è¼º¼ö(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 15:45~16:00 NOAC use in special situation (CKD, elderly & pregnancy) ȲÁ¾¹Î(°è¸íÀÇ´ë)

Åä·Ð 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:00~16:15 Discussion ¹ÚÁ¾¼º,Ȳ±â¿ø,¹Ú¿ëÈÖ,À̱âÈ«,ÀÓ¿µ¹Î,°íÁ¡¼®,Á¶ÇöÁØ,ÀÌÂùÈñ,ÀÌ¿µ¼ö(µ¿¾Æ´ëº´¿ø,¾ç»êºÎ»ê´ëº´¿ø,â¿ø°æ»ó´ëº´¿ø,Àü³²´ëº´¿ø,¼º°¡¸¦·Îº´¿ø,¿ø±¤´ëº´¿ø,´ë±¸ÆÄƼ¸¶º´¿ø,¿µ³²´ëº´¿ø,´ë±¸°¡Å縯´ëº´¿ø)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:15~16:40 Heart failure with supranormal ejection fraction: what evidence do we have? Ȳ¼®Àç(°æ»óÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 16:40~17:05 The role of lung ultrasound for management of heart failure in every day practice ÀÌ´©¸®(Àü³²ÀÇ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 17:05~17:30 New drugs for management of HCMP and ATTR amylodosis ±è⿬(´ë±¸Ä«Å縯)

Åä·Ð 10¿ù 28ÀÏ ¾Æ½ºÆ¼È£ÅÚ 22Ãþ ±×·£µåº¼·ë 17:30~17:40 Discussion ±è¼öÁø,¼­Á¤¼÷,±èÁ¤¼ö,¼ÛÁöÀº,ÃÖ°¡Èñ,¹èÁØÈ£,Á¤ÇØ¿ø,ÀÌÁ¤Àº(°í½Å´ëº¹À½º´¿ø,ÀÎÁ¦´ëºÎ»ê¹éº´¿ø,¾ç»êºÎ»ê´ëº´¿ø,¿¹¼öº´¿ø,Àü³²´ëº´¿ø,Æ÷Ç×¼¼¸í±âµ¶º´¿ø,´ë±¸°¡Å丯´ëº´¿ø,°è¸í´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѽÉÀåÇÐȸ ¿µÈ£³²Áöȸ ¿¬¼ö°­Á : 2023-10-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ºÐ´ç¼­¿ï´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú Åä¿äȸ(±Þ¼º ÀúÀ½³­Ã» Ä¡·á) : 2023-10-28
´ÙÀ½±Û 2023³â ´ëÇѳ»°úÇÐȸ Á¦74Â÷ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-10-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 38 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 36 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 32 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 28 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 32 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 51 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 18 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 27 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 25 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 24 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 22 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 29 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 29 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷